Latest News & Features
Europe
Two years since the UPC opened its doors, various developments might influence the UK government to reassess its position, write Amanda Ebbutt and Paul England of Taylor Wessing. 10 June 2025
Americas
US appeals court confirms validity of Acadia's Nuplazid patents | Decision fends off generics from MSN Laboratories and Aurobindo Pharma until 2030s. 10 June 2025
Americas
Office’s acting director lifts severe penalties against patent owner following Federal Circuit remand | Issues separate decision highlighting consequences of “lengthy awareness” of patent portfolio. 10 June 2025
Americas
Biotech company convinces judges over claim construction interpretation | Alnylam “acted as lexicographer” regarding a claim term | Win comes as Moderna suffers economic challenges. 5 June 2025
Big Pharma
Companies face increasingly complex decisions over what IP to use, particularly when collaborating. Muireann Bolger hears the dos and don’ts of protection from senior counsel. 5 June 2025
Americas
With nearly four decades of patent law experience—including decades at the USPTO—new senior patent counsel joins the firm’s Washington, DC office, bringing expertise in biotech, pharma, and chemical engineering. 5 June 2025
Europe
Survey launched ahead of LSIPR’s LSPN Europe conference | Seeks input on AI impact, Brexit, and Unitary Patent system | Focuses on patent challenges in pharma, biotech, medical devices, diagnostics to shape conference discussions in London. 4 June 2025
Americas
New York court finds Ethicon breached agreement with ChemImage over advanced imaging technologies | Parties dispute damages for IP ‘impairment’. 3 June 2025
Careers
The new hire brings over 20 years of experience in patent prosecution and litigation involving pharmaceuticals, molecular biology and medical technologies. 3 June 2025
Americas
The firm’s new practice unites Faber’s transactional and licensing abilities with Crowell’s regulatory and litigation services, bringing together 50 professionals and expanding into Boston. 3 June 2025